Skip to main content

Advertisement

Table 3 Multivariate regression adjusted total cost of treatment by provider setting, 2002 $ USD (N=145)

From: The value of effective public tuberculosis treatment: an analysis of opportunity costs associated with multidrug resistant tuberculosis in Latvia

  Inpatient Outpatient Prescription medication Overall
Type of infection     
Non MDR-TB Ref. Ref. Ref. Ref.
MDR-TB $18,729 (15,563, 21,893) *** $592 (−192, 1,375) $2,199 (1,956, 2,442)*** $21,520 (18,751, 24,288)***
Sex     
Female Ref. Ref. Ref. Ref.
Male $5,002 (1,362, 8,641) ** -$834 (1,859, 191) $228 (−41, 497) $4,395 (1,358, 7,433)**
Age group     
<25 Ref. Ref. Ref. Ref.
25-64 $4,310 (−1,294, 9,914) -$436 (−1,781, 909) $224 (−214, 661) $4,097 (−987, 9,181)
>=65 $6,244 (−993, 13,480) -$1,233 (−2,666, 199) 30 (−517, 577) $5,040 (−1,738, 11,818)
Outcome of treatment     
Not cured Ref. Ref. Ref. Ref.
Cured $7,707 (3,044, 12,371)*** $1,305 (328, 2,282) ** $923 (530, 1,315)*** $9,935 (5,370, 14,500)***
Vital status     
Alive Ref. Ref. Ref. Ref.
Dead -$4,070 (−12,424, 4,283) -$124 (−1,105, 857) -$65 (−919, 788) -$4,259 (−13,215, 4,696)
R2 .51 .10 .67 .63
N 145 145 145 145
  1. * denotes p<.05; **, p<.01; ***, p<.001.